FDA.reportPublic FDA data

Application 050555

Type
NDA
Sponsor
NOVARTIS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOBREXTOBRAMYCINOINTMENT;OPHTHALMIC0.3%YesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N050555-001TOBREXTOBRAMYCIN0.3%OINTMENT / OPHTHALMICRLD, RS, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 2 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2022-10-28 04:53 UTC2022-10N050555-001TOBREX0.3%OINTMENT / OPHTHALMICRLD, RS, Approved before 1982f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N050555-001TOBREX0.3%OINTMENT / OPHTHALMICRLD, RS, Approved before 1982e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N050555-001TOBREX0.3%OINTMENT / OPHTHALMICRLD, RS, Approved before 1982cb3db0bc1861…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06N050555-001TOBREX0.3%OINTMENT / OPHTHALMICRLD, RS, Approved before 1982a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TOBREXTOBRAMYCINNovartis Pharmaceuticals Corporation5b66bba3-cf97-4a9c-b618-ba5f277f20f62025-12-16Warnings, Adverse reactionsExact identifier
application applno (NDA): 050555
application number: NDA050555
ndc (product): 0078-0813

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 7 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0065-0644TOBREXtobramycinAlcon Laboratories, Inc.NDACurrent
0065-0644TOBREXtobramycinAlcon Laboratories, Inc.NDACurrent
0065-0644TOBREXtobramycinAlcon Laboratories, Inc.NDACurrent
0065-0644TOBREXtobramycinAlcon Laboratories, Inc.NDACurrent
0065-0644TOBREXtobramycinAlcon Laboratories, Inc.NDACurrent
0078-0813TOBREXtobramycinNovartis Pharmaceuticals CorporationNDACurrent
21695-458TobrextobramycinRebel Distributors CorpNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
67507SUPPL2021-05-17
67502SUPPL2021-05-17
62707SUPPL2020-04-28
62684SUPPL2020-04-27
38979SUPPL2004-07-21
38978SUPPL2004-07-21
30078SUPPL2004-07-21
7814SUPPL2004-07-21
38977SUPPL2003-03-26
38976SUPPL2003-03-26
30077SUPPL2003-03-26
17870SUPPL2003-03-26
7813SUPPL2003-03-26
7812SUPPL2003-03-26